MedTrace Logo

Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide

NCT03925987 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-12-15

No results posted yet for this study

Summary

Anxiety disorders affect over a quarter of the population, yet very little is known about the variables that predict treatment outcome. The planned study explores whether a patient's response to a physiological test involving inhalation of carbon dioxide predicts their response to exposure therapy.

Conditions

Interventions

BEHAVIORAL

Exposure therapy

10 weekly sessions of group-based exposure therapy

Sponsors & Collaborators

  • Laureate Institute for Brain Research, Inc.

    lead OTHER

Principal Investigators

  • Justin Feinstein, PhD · Principal Investigator

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-07
Primary Completion
2020-01-31
Completion
2020-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03925987 on ClinicalTrials.gov